Terms: = Liver cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Treatment
37 results:
1. Comparison of Integrase Strand Transfer Inhibitors (INSTIs) and Protease-Boosted Inhibitors (PIs) on the Reduction in Chronic Immune Activation in a Virally Suppressed, Mainly Male Population Living with HIV (PLWH).
Nitsotolis T; Kyriakoulis KG; Kollias A; Papalexandrou A; Kalampoka H; Mastrogianni E; Basoulis D; Psichogiou M
Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399618
[No Abstract] [Full Text] [Related]
2. Correlation between surrogate endpoints and overall survival in unresectable hepatocellular carcinoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Huang L; Kang D; Zhao C; Liu X
Sci Rep; 2024 Feb; 14(1):4327. PubMed ID: 38383730
[TBL] [Abstract] [Full Text] [Related]
3. Is surgical treatment of hepatocellular carcinoma at high-volume centers worth the additional cost?
Shaikh CF; Woldesenbet S; Munir MM; Lima HA; Moazzam Z; Endo Y; Alaimo L; Azap L; Yang J; Katayama E; Dawood Z; Pawlik TM
Surgery; 2024 Mar; 175(3):629-636. PubMed ID: 37741780
[TBL] [Abstract] [Full Text] [Related]
4. A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients.
Wu S; Lv M; Ma F; Feilong Z; Fang G; Zhang J
Eur J Clin Pharmacol; 2023 Sep; 79(9):1195-1204. PubMed ID: 37392366
[TBL] [Abstract] [Full Text] [Related]
5. Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology.
Huang Y; Wang X; Yan C; Li C; Zhang L; Zhang L; Liang E; Liu T; Mao J
Medicine (Baltimore); 2022 Oct; 101(43):e31437. PubMed ID: 36316840
[TBL] [Abstract] [Full Text] [Related]
6. CT images-based 3D convolutional neural network to predict early recurrence of solitary hepatocellular carcinoma after radical hepatectomy.
Cui H; Wang KY; Li WY; Zhu HB; Xiao LS; Liu L
Diagn Interv Radiol; 2022 Nov; 28(6):524-531. PubMed ID: 36287132
[TBL] [Abstract] [Full Text] [Related]
7. Predictors of post-recurrence survival in hepatocellular carcinoma patients following liver transplantation: Systematic review and meta-analysis.
Al-Ameri A; Yu X; Zheng S
Transplant Rev (Orlando); 2022 Jan; 36(1):100676. PubMed ID: 34999555
[TBL] [Abstract] [Full Text] [Related]
8. Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines.
Teng W; Chang TT; Yang HI; Peng CY; Su CW; Su TH; Hu TH; Yu ML; Yang HC; Wu JC
Hepatol Int; 2021 Dec; 15(6):1421-1430. PubMed ID: 34741723
[TBL] [Abstract] [Full Text] [Related]
9. Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agents.
Degasperi E; Perbellini R; D'Ambrosio R; Uceda Renteria SC; Ceriotti F; Perego A; Orsini C; Borghi M; Iavarone M; Bruccoleri M; Rimondi A; De Silvestri A; Sangiovanni A; Lampertico P
Aliment Pharmacol Ther; 2022 Feb; 55(3):350-359. PubMed ID: 34738664
[TBL] [Abstract] [Full Text] [Related]
10. The association between urate-lowering therapies and treatment-related adverse events, liver damage, and major adverse cardiovascular events (MACE): A network meta-analysis of randomized trials.
Zhang S; Xie Q; Xie S; Chen J; Deng Q; Zhong L; Guo J; Yu Y
Pharmacotherapy; 2021 Sep; 41(9):781-791. PubMed ID: 34170566
[TBL] [Abstract] [Full Text] [Related]
11. Differences in Survival Between First-Line Radiofrequency Ablation versus Surgery for Early-Stage Hepatocellular Carcinoma: A Population Study Using the Surveillance, Epidemiology, and End Results Database.
Lin Y; Pan XB
Med Sci Monit; 2020 May; 26():e921782. PubMed ID: 32461542
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and Safety of Percutaneous Argon-Helium Cryoablation for Hepatocellular Carcinoma Abutting the Diaphragm.
Yang Y; Zhang Y; Wu Y; Chen J; Liang B; Chen Q; Wang Q; Lyu J; Li Y; Mu F; Du D
J Vasc Interv Radiol; 2020 Mar; 31(3):393-400.e1. PubMed ID: 31987705
[TBL] [Abstract] [Full Text] [Related]
13. Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B.
Yip TC; Wong GL; Wong VW; Tse YK; Liang LY; Hui VW; Lee HW; Lui GC; Chan HL
J Hepatol; 2020 May; 72(5):847-854. PubMed ID: 31857194
[TBL] [Abstract] [Full Text] [Related]
14. Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization.
Lee JS; Lee HA; Jeon MY; Lim TS; Kim BK; Park JY; Kim DY; Ahn SH; Um SH; Han KH; Seo YS; Kim SU
Eur J Gastroenterol Hepatol; 2020 Jun; 32(6):739-747. PubMed ID: 31764406
[TBL] [Abstract] [Full Text] [Related]
15. Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood cancer Survivor Study.
Dietz AC; Seidel K; Leisenring WM; Mulrooney DA; Tersak JM; Glick RD; Burnweit CA; Green DM; Diller LR; Smith SA; Howell RM; Stovall M; Armstrong GT; Oeffinger KC; Robison LL; Termuhlen AM
Lancet Oncol; 2019 Oct; 20(10):1420-1431. PubMed ID: 31471158
[TBL] [Abstract] [Full Text] [Related]
16. Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma.
Liu X; Meng J; Xu H; Niu J
Medicine (Baltimore); 2019 Apr; 98(17):e15414. PubMed ID: 31027143
[TBL] [Abstract] [Full Text] [Related]
17. Detection of Hyperacute Reactions of Desacetylvinblastine Monohydrazide in a Xenograft Model Using Intravoxel Incoherent Motion DWI and R2* Mapping.
Liang J; Ma R; Chen H; Zhang D; Ye W; Shi C; Luo L
AJR Am J Roentgenol; 2019 Apr; 212(4):717-726. PubMed ID: 30699010
[TBL] [Abstract] [Full Text] [Related]
18. Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes.
Franco RA; Fan Y; Jarosek S; Bae S; Galbraith J
Am J Prev Med; 2018 Nov; 55(5 Suppl 1):S40-S48. PubMed ID: 30670200
[TBL] [Abstract] [Full Text] [Related]
19. Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study.
Fanotto V; Fornaro L; Bordonaro R; Rosati G; Rimassa L; Di Donato S; Santini D; Tomasello G; Leone F; Silvestris N; Stragliotto S; Scartozzi M; Giampieri R; Nichetti F; Antonuzzo L; Cinieri S; Avallone A; Pellegrino A; Melisi D; Vasile E; Gerratana L; Aprile G
J Geriatr Oncol; 2019 Jul; 10(4):591-597. PubMed ID: 30551958
[TBL] [Abstract] [Full Text] [Related]
20. Predictive factors of benefit from iodine-125 brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis.
Lin J; Jiang H; Yang W; Jiang N; Zheng Q; Huang N; Wang X; Li A; Huang J
Brachytherapy; 2019; 18(2):233-239. PubMed ID: 30467014
[TBL] [Abstract] [Full Text] [Related]
[Next]
